Most Popular Articles

Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy

Brinton, Louise A.; Brogan, Donna R.; Coates, Ralph J.; More

Menopause. 25(11):1195-1200, November 2018.

NAMS-gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy

Utian, Wulf H.; Schiff, Isaac

Menopause. 25(11):1172-1179, November 2018.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Labrie, Fernand; Archer, David F.; Koltun, William; More

Menopause. 25(11):1339-1353, November 2018.

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Maki, Pauline M.; Kornstein, Susan G.; Joffe, Hadine; More

Menopause. 25(10):1069-1085, October 2018.

Continuation of postmenopausal hormone replacement therapy: comparison of cyclic versus continuous combined schedules

Ettinger, Bruce; Li, De-Kun; Klein, Raymond

Menopause. 25(11):1187-1190, November 2018.

Long-term postmenopausal estrogen therapy may be associated with increased risk of breast cancer: a cohort study

Ettinger, Bruce; Quesenberry, Charles; Schroeder, David A.; More

Menopause. 25(11):1191-1194, November 2018.

Menopause 25th Anniversary Commemorative Issue

Menopause. 25(11):1171, November 2018.

Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study

Paganini-Hill, Annlia; Corrada, Maria M.; Kawas, Claudia H.

Menopause. 25(11):1256-1261, November 2018.

17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis

Rioux, Jacques Emile; Devlin, M. Corinne; Gelfand, Morrie M.; More

Menopause. 25(11):1208-1213, November 2018.

Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy

Sullivan, Jay M.; Shala, Bashar A.; Miller, Leslie A.; More

Menopause. 25(11):1180-1186, November 2018.

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy

Laliberté, François; Dea, Katherine; Duh, Mei Sheng; More

Menopause. 25(11):1297-1305, November 2018.

A Selection of Notable Papers from the Past 25 Years

Menopause. 25(11):1388-1390, November 2018.

Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women

Bhavnani, Bhagu R.; Cecutti, Anthony; Gerulath, Alan; More

Menopause. 25(11):1214-1223, November 2018.

Evolution of postmenopausal hormone therapy between 2002 and 2009

Ettinger, Bruce; Wang, Sharon M.; Leslie, R. Scott; More

Menopause. 25(11):1306-1312, November 2018.

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause. 25(11):1362-1387, November 2018.

Predictors of decreased libido in women during the late reproductive years

Gracia, Clarisa R.; Sammel, Mary D.; Freeman, Ellen W.; More

Menopause. 25(11):1238-1243, November 2018.

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

Kroll, Robin; Archer, David F.; Lin, Yuhua; More

Menopause. 25(2):133-138, February 2018.

Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression

Clarkson, Thomas B.

Menopause. 25(11):1262-1274, November 2018.

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women

Huang, Alison J.; Sawaya, George F.; Vittinghoff, Eric; More

Menopause. 25(11):1286-1290, November 2018.

Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells

Seeger, Harald; Wallwiener, Diethelm; Mueck, Alfred O.

Menopause. 8(1):5-9, January 2001.

Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy

Brotman, Rebecca M.; Shardell, Michelle D.; Gajer, Pawel; More

Menopause. 25(11):1321-1330, November 2018.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

History of hot flashes and aortic calcification among postmenopausal women

Thurston, Rebecca C.; Kuller, Lewis H.; Edmundowicz, Daniel; More

Menopause. 25(11):1291-1296, November 2018.

Compounded non-FDA–approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey

Pinkerton, JoAnn V.; Constantine, Ginger D.

Menopause. 23(4):359-367, April 2016.

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy

Rocca, Walter A.; Grossardt, Brandon R.; Geda, Yonas E.; More

Menopause. 25(11):1275-1285, November 2018.

Caloric restriction reduces age at menopause: the effect of the 1944-1945 Dutch famine

Elias, Sjoerd G.; van Noord, Paulus A.H.; Peeters, Petra H.M.; More

Menopause. 25(11):1232-1237, November 2018.

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Glazer, Clara; More

Menopause. 22(4):384-390, April 2015.

What's in a name: are menopausal “hot flashes” a symptom of menopause or a manifestation of neurovascular dysregulation?

Miller, Virginia M.; Kling, Juliana M.; Files, Julia A.; More

Menopause. 25(6):700-703, June 2018.

Effects of stretching on menopausal and depressive symptoms in middle-aged women: a randomized controlled trial

Kai, Yuko; Nagamatsu, Toshiya; Kitabatake, Yoshinori; More

Menopause. 23(8):827-832, August 2016.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Tissue selective estrogen complex (TSEC): a review

Pickar, James H.; Boucher, Matthieu; Morgenstern, Diana

Menopause. 25(9):1033-1045, September 2018.

Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects

Diano, Sabrina; Horvath, Tamas L.; Mor, Gil; More

Menopause. 25(11):1201-1207, November 2018.

The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause

Utian, Wulf H.; Janata, Jeffrey W.; Kingsberg, Sheryl A.; More

Menopause. 25(11):1224-1231, November 2018.

Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN)

Avis, Nancy E.; Zhao, Xinhua; Johannes, Catherine B.; More

Menopause. 25(11):1244-1255, November 2018.

Physiologically assessed hot flashes and endothelial function among midlife women

Thurston, Rebecca C.; Chang, Yuefang; Barinas-Mitchell, Emma; More

Menopause. 25(11):1354-1361, November 2018.

Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis

McClung, Michael R.; Harvey, Nicholas C.; Fitzpatrick, Lorraine A.; More

Menopause. 25(7):767-771, July 2018.

Menopause Board Members: Past and Present

Menopause. 25(11):1391, November 2018.

Prevalence of osteopenia and osteoporosis in Thai women

Limpaphayom, Khunying Kobchitt; Taechakraichana, Nimit; Jaisamrarn, Unnop; More

Menopause. 8(1):65-69, January 2001.

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

Cintron, Dahima; Lahr, Brian D.; Bailey, Kent R.; More

Menopause. 25(2):145-153, February 2018.

Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years

Gartoulla, Pragya; Worsley, Roisin; Bell, Robin J.; More

Menopause. 25(11):1331-1338, November 2018.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher A.; More

Menopause. 25(1):11-20, January 2018.

TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol

Archer, David F.; Constantine, Ginger D.; Simon, James A.; More

Menopause. 24(5):510-516, May 2017.

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Constantine, Ginger D.; Archer, David F.; Graham, Shelli; More

Menopause. 23(10):1075-1082, October 2016.

Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial

Diem, Susan J.; Guthrie, Katherine A.; Mitchell, Caroline M.; More

Menopause. 25(10):1086-1093, October 2018.

A theory of eu-estrogenemia: a unifying concept

Turner, Ralph J.; Kerber, Irwin J.

Menopause. 24(9):1086-1097, September 2017.

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy

Constantine, Ginger D.; Simon, James A.; Pickar, James H.; More

Menopause. 24(4):409-416, April 2017.

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

Simon, James A.; Portman, David J.; Kaunitz, Andrew M.; More

Menopause. 20(10):1027-1035, October 2013.

Sleep in menopause: differential effects of two forms of hormone replacement therapy

Montplaisir, Jacques; Lorrain, Jacques; Denesle, Régine; More

Menopause. 8(1):10-16, January 2001.

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Portman, David J.; Bachmann, Gloria A.; Simon, James A.; More

Menopause. 20(6):623-630, June 2013.

SLCO1B1 genetic variation and hormone therapy in menopausal women

Moyer, Ann M.; de Andrade, Mariza; Faubion, Stephanie S.; More

Menopause. 25(8):877-882, August 2018.

Sexual activity and function assessment in middle-aged Chinese women using the female sexual function index

Zhang, Caiyun; Cui, Liping; Zhang, Lizhi; More

Menopause. 24(6):669-676, June 2017.

Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort: novel results show menopause-related differences in blood count

Kovanen, Vuokko; Aukee, Pauliina; Kokko, Katja; More

Menopause. 25(9):1020-1032, September 2018.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Deciphering the complex relationship between menopause and heart disease: 25 years and counting

Stuenkel, Cynthia A.

Menopause. 25(9):955-962, September 2018.

Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition

Gracia, Clarisa R.; Sammel, Mary D.; Freeman, Ellen W.; More

Menopause. 12(2):128-135, March-April 2005.

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause. 24(7):728-753, July 2017.

Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment

St. Germain, Alison; Peterson, Charles T.; Robinson, Jennifer G.; More

Menopause. 8(1):17-26, January 2001.

Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study

Waetjen, L. Elaine; Crawford, Sybil L.; Chang, Po-Yin; More

Menopause. 25(10):1094-1104, October 2018.

Cycle and hormone changes during perimenopause: the key role of ovarian function

Burger, Henry G.; Hale, Georgina E.; Dennerstein, Lorraine; More

Menopause. 15(4):603-612, July-August 2008.

Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial

Chlebowski, Rowan T.; Cirillo, Dominic J.; Eaton, Charles B.; More

Menopause. 25(11):1313-1320, November 2018.

Contraception for midlife women: a review

Miller, Taniqua A.; Allen, Rebecca H.; Kaunitz, Andrew M.; More

Menopause. 25(7):817-827, July 2018.

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

Portman, David J.; Kaunitz, Andrew M.; Kazempour, Kazem; More

Menopause. 21(10):1082-1090, October 2014.

One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus

Simon, James A.; Lin, Vivian H.; Radovich, Cathy; More

Menopause. 20(4):418-427, April 2013.

Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial

Simon, James A.; Archer, David F.; Kagan, Risa; More

Menopause. 24(9):1003-1010, September 2017.

Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study: Erratum

Menopause. 25(10):1169, October 2018.

The big, bad obesity pandemic

Regestein, Quentin R.

Menopause. 25(2):129-132, February 2018.

Drug holidays in women treated for postmenopausal osteoporosis

McClung, Michael R.

Menopause. 25(10):1152-1154, October 2018.

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study

Coelingh Bennink, Herjan J.T.; Verhoeven, Carole; Zimmerman, Yvette; More

Menopause. 24(6):677-685, June 2017.

Changes in sexual function among midlife women: “I’m older… and I’m wiser”

Thomas, Holly N.; Hamm, Megan; Hess, Rachel; More

Menopause. 25(3):286-292, March 2018.

Menopausal progesterone replacement and sleep quality

Regestein, Quentin

Menopause. 8(1):3-4, January 2001.

The cross-sectional association between chemerin and bone health in peri/pre and postmenopausal women: results from the EPIC-Potsdam study

Menzel, Juliane; Biemann, Ronald; Aleksandrova, Krasimira; More

Menopause. 25(5):574-578, May 2018.

The impact of hormones on menopausal sexuality: a literature review

Bachmann, Gloria A.; Leiblum, Sandra R.

Menopause. 11(1):120-130, January-February 2004.

Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women

Pinkerton, JoAnn V.; Santoro, Nanette

Menopause. 22(9):926-936, September 2015.

Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001

Soules, Michael R.; Sherman, Sherry; Parrott, Estella; More

Menopause. 8(6):402-407, November 2001.

Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain

Chen, Shuhua; Kumar, Narender; Mao, Zisu; More

Menopause. 25(10):1138-1151, October 2018.

Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival

Uršic-Vršaj, Marjetka; Bebar, Sonja; Žakelj, Maja Primic

Menopause. 8(1):70-75, January 2001.

A conversation about hormone therapy: is there an appropriate dose, route, and duration of use?

Menopause. 24(11):1221-1235, November 2017.

The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism

Clifton-Bligh, Phillip B.; Baber, Rodney J.; Fulcher, Greg R.; More

Menopause. 8(4):259-265, July 2001.

Daily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women

Burleson, Mary H.; Todd, Michael; Trevathan, Wenda R.

Menopause. 17(1):87-95, January 2010.

The role of nursing with the journal Menopause and NAMS over the last 25 years: contributions and collaboration

Pace, Diane T.; Chism, Lisa Astalos; Kelly, Linda

Menopause. 25(6):579-585, June 2018.

Aging ovary and the role for advanced glycation end products

Pertynska-Marczewska, Magdalena; Diamanti-Kandarakis, Evanthia

Menopause. 24(3):345-351, March 2017.

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review

Simon, James A.; Goldstein, Irwin; Kim, Noel N.; More

Menopause. 25(7):837-847, July 2018.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies

Hallajzadeh, Jamal; Khoramdad, Maliheh; Izadi, Neda; More

Menopause. 25(10):1155-1164, October 2018.

Psychometric properties of the Chinese version of the Menopause-Specific Quality-of-Life questionnaire

Nie, Guangning; Yang, Hongyan; Liu, Jian; More

Menopause. 24(5):546-554, May 2017.

Menopause and exercise

Grindler, Natalia M.; Santoro, Nanette F.

Menopause. 22(12):1351-1358, December 2015.

A systematic review of herbal medicinal products for the treatment of menopausal symptoms

Huntley, Alyson L.; Ernst, Edzard

Menopause. 10(5):465-476, September 2003.

Letters to the Editor

Cutter, Christopher

Menopause. 16(2):422, March 2009.

Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

Menopause. 7(6):422, November 2000.

Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study

Burke, Gregory L.; Legault, Claudine; Anthony, Mary; More

Menopause. 10(2):147-153, March 2003.

Polycystic ovarian syndrome and the risk of subsequent primary ovarian insufficiency: a nationwide population-based study

Pan, Mei-Lien; Chen, Li-Ru; Tsao, Hsiao-Mei; More

Menopause. 24(7):803-809, July 2017.

Bioidentical hormone therapy: a review

Boothby, Lisa A.; Doering, Paul L.; Kipersztok, Simon

Menopause. 11(3):356-367, May-June 2004.

Hormonal contraception and risk of breast cancer: a closer look

Kaunitz, Andrew M.; Pinkerton, JoAnn V.; Manson, JoAnn E.

Menopause. 25(5):477-479, May 2018.

Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality

Hartmann, Uwe; Philippsohn, Susanne; Heiser, Kristina; More

Menopause. 11(6 Part 2 of 2):726-740, November-December 2004.

Association between habitual physical activity and lower cardiovascular risk in premenopausal, perimenopausal, and postmenopausal women: a population-based study

Colpani, Verônica; Oppermann, Karen; Spritzer, Poli Mara

Menopause: The Journal of The North American Menopause Society. 20(5):525-531, May 2013.

Dietary strategies for weight loss in midlife women

Varady, Krista A.

Menopause. 25(6):697-699, June 2018.

A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol

Pickar, James H.; Amadio, Julia M.; Hill, John M.; More

Menopause. 23(5):506-510, May 2016.

Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women: a double-blind randomized controlled trial

Kim, Sun Young; Seo, Seok Kyo; Choi, Young Mi; More

Menopause. 19(4):461-466, April 2012.

Clinical trials in menopause

Marko, Kathryn I.; Simon, James A.

Menopause. 25(2):217-230, February 2018.

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial

Simon, James A.; Kingsberg, Sheryl A.; Shumel, Brad; More

Menopause. 21(6):633-640, June 2014.

Journal Logo

Secondary Logo

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

In Brief:

Abstract:

Abstract:

Abstract:

Abstract:

In Brief:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract: